
The Synthetic Biology Technology Market study describes how the technology industry is evolving and how major and emerging players in the industry are responding to long term opportunities and short-term challenges they face. One major attraction about Synthetic Biology Technology Industry is its growth rate. Many major technology players - including Thermo Fisher Scientific, Inc. (United States), Merck KGaA (Germany), Agilent Technologies, Inc (United States), Novozymes A/S (Denmark), Ginkgo Bioworks (United States), Amyris (United States), Precigen, Inc. (United States), GenScript (China), Twist Bioscience (United States), Synthetic Genomics (United States), Codexis (United States), Synthego (United States), Creative Enzymes (United States), Eurofins Scientific (Luxembourg).